IndraLab

Statements


KCNQ4 activates LIPC. 4 / 4
| 4

reach
"It has been demonstrated that HL in certain DFNA2 families is caused by mutations in KCNQ4, which are centromeric to MACF1."

reach
"As of October 2021, around 72 mutations in KCNQ4 have been reported to cause HL in humans, with a potential genotype–phenotype correlation, in which the truncating variants have been associated with severe phenotype as compared to non-truncating variants of KCNQ4 [26]."
| PMC

reach
"Conversely, screening of 80 hearing impaired families did not result in the identification of a single mutation in KCNQ4 causing HL (Talebizadeh et al., 1999)."

reach
"VPA is a candidate drug that slows down HL progression to increase the time window for the definite treatment of KCNQ4 p.W276S variant that induces genetic HL."